When vaccines can end the pandemic depends on many factors such as the effectiveness of the vaccine, the number of people vaccinated, how much attention is paid to mask, distance and cleaning measures after vaccination. The data obtained to date do not provide sufficient information about when the vaccine will end the pandemic.
ARE COVID-19 VACCINES SAFE?
No vaccine can be approved or released on the market without conducting phase studies, and without transparently sharing the results of these studies with the relevant authorities. The organization conducting vaccine studies must comply with international quality standards during the development and production process. These standards are Good Laboratory Practices (GLP), Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP).
In addition, during the phase studies, when a situation that is thought to be related to the vaccine and significantly affects human health is detected, the studies are stopped. Studies are carried out only if it is ensured that the problem is not related to the vaccine, and if vaccination is performed, it is continued from where it left off. In this context, in the phase studies of the COVID-19 vaccines started to be applied in our country, no side effects that would cause the study to be stopped were encountered. There is no hesitation about its safety during the implementation phase.